1. Caro JJ, Ward AJ, O'Brien JA. Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. Diabetes Care. 2002. 25:476–481.

2. Lim DJ, Kwon HS, Kim HS, Lee JH, Ko SH, Lee JM, Kim SR, Lee WC, Son HS, Cha BY, Lee KW, Son HY, Kang SK, Yoon KH. Clinical characteristics of the diabetic patients managed at the different medical institutions in Seoul and Gyeonggi province. The Korean J of Medicine. 2006. 71:173–181.

3. Task Force Team For Basic Statistical Study of Korean Diabetes Mellitus. Diabetes in Korea 2007. 2007. 1st ed. Seoul: Goldfishery;57.

4. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW. American Diabetes Association. Nephropathy in Diabetes. Diabetes Care. 2004. 27:suppl 1. S79–S83.

5. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R. American Diabetes Association. Retinopathy in Diabetes. Diabetes Care. 2004. 27:suppl 1. S84–S87.

6. Gaede P, Valentine WJ, Palmer AJ, Tucker DM, Lammert M, Parving HH, Pedersen O. Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes. Results and projections from the Steno-2 study. Diabetes Care. 2008. 31:1510–1515.

7. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005. 43:521–530.